Thus, even prior to the vaccination, the older CLL patients were characterized by significantly lower numbers of the S protein-specific T cells (see Supplementary Table S1), and this difference remained until d49 post vaccination, particularly, among the CD4+ T cells (Table 3). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.